The GHU has made substantial investment in NCD healthcare programmes across 40 L MIC countries (2022–2026), generating a significant volume of programme data. However, no structured economic case has been developed to demonstrate the value of the GHU’s activities in NCD care programmes.

Although the GHU and other non-governmental organisations can improve health in the period in which their programmes operate, care for NCDs must become sustainable for the long term, and securing domestic financing is the key to this. A compelling economic argument that investing in programmes treating NCDs provides a positive impact to the economy is a strong lever to influence domestic health financing decisions.

This principle aim of this position is to address that gap by building a health economic evidence base that demonstrates the value of GHU programmes, to support the proposition to governments that increased domestic healthcare financing can be an economic driver rather than ...